3401 Burgdorf, ch
+41 (34) 4244159
Insulin pen from Ypsomed to be launched in GermanyBurgdorf, )
B. Braun is to distribute the reusable insulin pen developed by the Burgdorf-based diabetes specialist together with its human insulins, which enjoy an established market presence. The major German corporate group has been active in the German diabetes market for many years.
The ServoPen® impresses with its quality workmanship and its high level of user-friendliness thanks to its semi-automatic mode of operation. These characteristics played an important part in B. Braun's decision to opt for the Swiss-manufactured insulin pen.
'Ypsomed is proud to be able to produce the Omnifill® pen on behalf of B. Braun', confirms Simon Michel, member of the executive management of the Ypsomed Group, and adds: 'This quality product will allow B. Braun to meet the highest requirements in terms of patient comfort and user-friendliness.'
Germany is Europe's largest insulin market with a high rate of growth. Of all insulin dependent diabetics, 95% use insulin pens. Currently, approximately six million people in Germany are diagnosed with diabetes mellitus. Including undetected cases, the total number of diabetics is estimated to be ten million. Experts predict that the number of peo-ple suffering from diabetes will double over the next ten years.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.